Thermo Fisher Scientific (TMO) Current Deferred Tax Assets (2009 - 2015)

Thermo Fisher Scientific (TMO) has reported Current Deferred Tax Assets for 7 consecutive years, with $263.3 million the latest figure, recorded in Q3 2015.

• For the quarter ending Q3 2015, Current Deferred Tax Assets rose 14.18% year-over-year to $263.3 million; the trailing twelve-month figure through Sep 2015 stood at $263.3 million (up 14.18% YoY), and the FY2014 full-year result was $303.3 million, up 57.56% from the prior year.
• Current Deferred Tax Assets eased to $263.3 million in Q3 2015 per TMO's latest filing, from $283.5 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $303.3 million in Q4 2014 and bottomed at $157.8 million in Q4 2011.
• Historically, Current Deferred Tax Assets has averaged $212.8 million across 5 years, with a median of $195.2 million in 2011.
• The sharpest annual moves came in 2011 and 2014: Current Deferred Tax Assets slipped 12.96% in 2011, then surged 57.56% in 2014.
• Over 5 years, Current Deferred Tax Assets stood at $157.8 million in 2011, then gained by 15.34% to $182.0 million in 2012, then rose by 5.77% to $192.5 million in 2013, then surged by 57.56% to $303.3 million in 2014, then slipped by 13.19% to $263.3 million in 2015.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $263.3 million, $283.5 million, and $299.4 million for Q3 2015, Q2 2015, and Q1 2015 respectively.